- $79.88bn
- $105.73bn
- $247.12bn
- 84
- 74
- 75
- 92
Annual balance sheet for Cigna, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-Q | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 11,513 | 6,001 | 6,829 | 8,747 | 8,215 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 12,191 | 15,071 | 17,218 | 17,722 | 24,227 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 27,799 | 36,134 | 30,122 | 37,351 | 48,870 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4,757 | 4,143 | 3,774 | 4,065 | 3,654 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 155,451 | 154,889 | 143,885 | 152,761 | 155,881 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 36,022 | 43,572 | 41,225 | 48,716 | 57,979 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 105,130 | 107,777 | 99,210 | 106,538 | 114,848 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 50,321 | 47,112 | 44,675 | 46,223 | 41,033 |
| Total Liabilities & Shareholders' Equity | 155,451 | 154,889 | 143,885 | 152,761 | 155,881 |
| Total Common Shares Outstanding |